Skip to main content
Journal of Hematology & Oncology logoLink to Journal of Hematology & Oncology
. 2022 Oct 24;15:151. doi: 10.1186/s13045-022-01371-8

Correction: Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets

Rui Qin 1, Feng‑Ming You 1, Qian Zhao 2, Xin Xie 3, Cheng Peng 1, Gu Zhan 1,, Bo Han 1,
PMCID: PMC9594967  PMID: 36280887

Correction to: Journal of Hematology & Oncology (2022) 15:133 https://doi.org/10.1186/s13045-022-01350-z

The original article [1] mistakenly omitted co-corresponding authorship of co-author, Gu Zhan. This has since been restored.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Gu Zhan, Email: zhangu@cdutcm.edu.cn.

Bo Han, Email: hanbo@cdutcm.edu.cn.

References

  • 1.Qin R, et al. Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets. J Hematol Oncol. 2022;15:133. doi: 10.1186/s13045-022-01350-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Hematology & Oncology are provided here courtesy of BMC

RESOURCES